Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

8.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
8.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.3K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.3K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.2K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

3.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alternative antigen to defuse SARS-CoV-2 delta variant and its ensuing evolutionary lineage.

Expert opinion on therapeutic targets·2021
Same author

Artificial Intelligence Deconstructs Drug Targeting <i>In Vivo</i> by Leveraging a Transformer Platform.

ACS medicinal chemistry letters·2021
Same author

Molecular Biology Clues Portray SARS-CoV-2 as a Gain-of-Function Laboratory Manipulation of Bat CoV RaTG13.

ACS medicinal chemistry letters·2021
Same author

Artificial Intelligence Teaches Drugs to Target Proteins by Tackling the Induced Folding Problem.

Molecular pharmaceutics·2020
Same author

Artificial Intelligence Steering Molecular Therapy in the Absence of Information on Target Structure and Regulation.

Journal of chemical information and modeling·2019
Same author

Drug-based cancer therapy to overcome immune resistance by steering tumor evolution.

Expert opinion on drug discovery·2018

Related Experiment Video

Updated: Nov 1, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.2K

Artificial Intelligence Set to Reverse Engineer Drug Targeting in the Cell.

Ariel Fernández1,2

  • 1Daruma Institute for AI in Pharmaceutical Research, AF Innovation Pharma Consultancy, GmbH, 4000 Pemberton Court, Winston-Salem, North Carolina 27106, United States.

ACS Pharmacology & Translational Science
|June 21, 2021
PubMed
Summary

Artificial intelligence is revolutionizing drug discovery by enabling computational modeling of protein folding within living cells. This breakthrough allows for the study of drug-induced structural adaptations, advancing therapeutic development.

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.1K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.7K

Related Experiment Videos

Last Updated: Nov 1, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.2K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.1K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.7K

Area of Science:

  • Biochemistry
  • Computational Biology
  • Drug Discovery

Background:

  • Therapeutic drugs must target proteins within the cellular environment, not solely in laboratory settings.
  • Current computational methods struggle to model the complex process of drug-induced protein folding within a living organism (in vivo).

Purpose of the Study:

  • To explore the potential of artificial intelligence (AI) in modeling in vivo drug-induced protein folding.
  • To overcome the limitations of current computational approaches in predicting structural adaptations of proteins within cells.

Main Methods:

  • Leveraging artificial intelligence to enhance molecular dynamics simulations.
  • Developing methods to deconstruct the cooperative effects influencing protein structural adaptation in vivo.

Main Results:

  • AI-powered molecular dynamics show promise for modeling in vivo protein folding.
  • The study outlines a pathway to computationally analyze drug-target interactions within the cellular context.

Conclusions:

  • Artificial intelligence offers a transformative approach to studying drug-induced protein folding in vivo.
  • This advancement could significantly accelerate the design and development of more effective therapeutic drugs.